國立虎尾科技大學 |

Handbook of Biologics for Rheumatological Disorders

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Handbook of Biologics for Rheumatological Disorders/ edited by Neeraj Jain, Lalit Duggal.
其他作者:	Duggal, Lalit.
面頁冊數:	X, 288 p.online resource. :
Contained By:	Springer Nature eBook
標題:	Internal Medicine. -
電子資源:	https://doi.org/10.1007/978-981-16-7200-2
ISBN:	9789811672002

Handbook of Biologics for Rheumatological Disorders
Handbook of Biologics for Rheumatological Disorders[electronic resource] /edited by Neeraj Jain, Lalit Duggal. - 1st ed. 2022. - X, 288 p.online resource.

History of Biologics -- Biologics in Rheumatoid Arthritis -- Biologics in Spondylarthritis -- Biologics in Psoriatic Arthritis -- Biologics in Gout -- Biologics in Lupus -- Biologics in Sjogren’s Syndrome -- Biologics in Systemic Sclerosis -- Biologics in Inflammatory Myopathies -- Biologics in ANCA Associated Vasculitis -- Biologics inBehcet's Syndrome -- Biologicsin Takayasu's Arteritis -- Biologics in Interstitial lung disease in Rheumatological conditions -- Biologics in Osteoporosis -- Biologics in Osteoarthritis -- Biologics in JIA -- Biologics in Paediatric CTD -- JAK inhibitors in Rheumatology -- Biologics in Rheumatic disease with Infections -- Biologics in Rheumatological conditions with Malignancy -- Biologics in Uveitis -- Biologics in Sarcoidosis -- Biologics in IgG4-RD -- Biosimilar in Rheumatology -- Off label use of Biologics in Rheumatological disorders -- Biologics & Ethical issues in Rheumatology -- Patient consent for use of biologics.

Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens. This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field. This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest.

ISBN: 9789811672002

Standard No.: 10.1007/978-981-16-7200-2doiSubjects--Topical Terms:

668583
Internal Medicine.

LC Class. No.: RC1-1245

Dewey Class. No.: 616

Handbook of Biologics for Rheumatological Disorders
LDR:03851nam a22003975i 4500 001 1089661
003 DE-He213
005 20220720081346.0
007 cr nn 008mamaa
008 221228s2022 si | s |||| 0|eng d
020 $a 9789811672002 $9 978-981-16-7200-2
024 7 $a 10.1007/978-981-16-7200-2 $2 doi
035 $a 978-981-16-7200-2
050 4 $a RC1-1245
072 7 $a MJ $2 bicssc
072 7 $a MED083000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616 $2 23
245 1 0 $a Handbook of Biologics for Rheumatological Disorders $h [electronic resource] / $c edited by Neeraj Jain, Lalit Duggal.
250 $a 1st ed. 2022.
264 1 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2022.
300 $a X, 288 p. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a History of Biologics -- Biologics in Rheumatoid Arthritis -- Biologics in Spondylarthritis -- Biologics in Psoriatic Arthritis -- Biologics in Gout -- Biologics in Lupus -- Biologics in Sjogren’s Syndrome -- Biologics in Systemic Sclerosis -- Biologics in Inflammatory Myopathies -- Biologics in ANCA Associated Vasculitis -- Biologics inBehcet's Syndrome -- Biologicsin Takayasu's Arteritis -- Biologics in Interstitial lung disease in Rheumatological conditions -- Biologics in Osteoporosis -- Biologics in Osteoarthritis -- Biologics in JIA -- Biologics in Paediatric CTD -- JAK inhibitors in Rheumatology -- Biologics in Rheumatic disease with Infections -- Biologics in Rheumatological conditions with Malignancy -- Biologics in Uveitis -- Biologics in Sarcoidosis -- Biologics in IgG4-RD -- Biosimilar in Rheumatology -- Off label use of Biologics in Rheumatological disorders -- Biologics & Ethical issues in Rheumatology -- Patient consent for use of biologics.
520 $a Biologics have revolutionized the treatment of autoimmune diseases due to their efficacy, speed of onset, and tolerability. The development of new agents and expanded use of existing agents continues to be a highly active area of investigation among rheumatic diseases, with a multitude of innovative therapeutic strategies in various stages of development. Although the story of treatments continues rapidly, therapeutic research in some conditions is hindered by the rarity of the disease, variation in phenotype, and concerns about toxicity. This fast-paced development of therapeutics,necessitates immediate evaluation of individual biologic agents and their best use in the new treatment regimens. This book provides an inclusive approach with the existing evidence concerning effectiveness and implications on the usage of biologics in treating various rheumatologic disorders. It also covers the evidence behind the rational use of these agents in varied autoimmune diseases. This manual also offers a complete overview of the existing & futuristic biologic treatments, and draws recommendations on how to standardize the most suitable regimen for a specific patient in the context of current guidelines. The handbook of Biologics in Rheumatology serves as a present and concise compendium to the modern therapeutic developments in the field. This book is likely to benefit clinicians, residents, fellow and other healthcare workers dealing with rheumatological disorders, and also hard-core Rheumatologists, who are looking for a quick recap of Biologics of their interest.
650 1 4 $a Internal Medicine. $3 668583
650 0 $a Internal medicine. $3 644638
700 1 $a Duggal, Lalit. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1396954
700 1 $a Jain, Neeraj. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1396953
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811671999
776 0 8 $i Printed edition: $z 9789811672019
776 0 8 $i Printed edition: $z 9789811672026
856 4 0 $u https://doi.org/10.1007/978-981-16-7200-2
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)